DBC1 Antikörper (N-Term)
Kurzübersicht für DBC1 Antikörper (N-Term) (ABIN796876)
Target
Alle DBC1 (BRINP1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Endogenous levels of total human DBC1. Species Crossreactivity: Equine, monkey, mouse and rat.
-
Aufreinigung
- Protein A purified
-
Immunogen
-
Synthetic peptide corresponding to residues near the amino terminus of human DBC1
Type of Immunogen: Synthetic peptide -
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: IF, IP, WB (1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- 10 mM sodium HEPES, pH 7.5, 150 mM sodium chloride, 100 μg/mL BSA, 50 % glycerol
-
Handhabung
- Aliquot to Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for at least 1 year.
-
-
- DBC1 (BRINP1) (Bone Morphogenetic Protein/retinoic Acid Inducible Neural-Specific 1 (BRINP1))
-
Andere Bezeichnung
- BRINP1 / DBC1
-
Hintergrund
-
Name/Gene ID: BRINP1
Synonyms: BRINP1, DBC1, DBCCR1, Deleted in bladder cancer 1, Protein FAM5A, FAM5A -
Gen-ID
- 1620
-
UniProt
- O60477
Target
-